Scientists at Karachi’s Dow University of Health Sciences (DUHS) believe Pakistan is likely to become the first country to complete the research on intravenous immunoglobulin (C-IVIG) therapy for the treatment coronavirus. The scientist conducting the clinical trials needed to introduce the treatment at a mass level say that ‘severe’ patients who had received the product had a 100 percent recovery rate.